Comparison of Vildagliptin and Pioglitazone in Korean Patients with Type 2 Diabetes Inadequately Controlled with Metformin
BackgroundWe compared the efficacies of vildagliptin (50 mg twice daily) relative to pioglitazone (15 mg once daily) as an add-on treatment to metformin for reducing glycosylated hemoglobin (HbA1c) levels in Korean patients with type 2 diabetes.MethodsThe present study was a multicenter, randomized,...
Main Authors: | , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Diabetes Association
2016-04-01
|
Series: | Diabetes & Metabolism Journal |
Subjects: | |
Online Access: | https://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-40-230.pdf |